13F HOLDINGS REPORT
Prosight Management, LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001420506-25-000459
Total Value
$361.8M
Positions
36
Other Managers
0
Confidential Omitted
No
Holdings (36)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | GALAPAGOS NV | GLPGF | 1,025,000 | $28.2M | 7.79% |
| 2 | ACADIA HEALTHCARE COMPANY IN | ACHC | 692,000 | $27.4M | 7.58% |
| 3 | BRIDGEBIO PHARMA INC | BBIO | 995,000 | $27.3M | 7.55% |
| 4 | MEIRAGTX HLDGS PLC | MGTX | 4,390,837 | $26.7M | 7.39% |
| 5 | ABCELLERA BIOLOGICS INC | ABCL | 7,350,000 | $21.5M | 5.95% |
| 6 | ADC THERAPEUTICS SA | ADCT | 9,515,000 | $18.9M | 5.23% |
| 7 | MIRUM PHARMACEUTICALS INC | MIRM | 451,127 | $18.7M | 5.16% |
| 8 | ICON PLC | ICLR | 85,000 | $17.8M | 4.93% |
| 9 | ROIVANT SCIENCES LTD | ROIV | 1,500,000 | $17.7M | 4.90% |
| 10 | JANUX THERAPEUTICS INC | JANX | 329,768 | $17.7M | 4.88% |
| 11 | SCHRODINGER INC | SDGR | 720,500 | $13.9M | 3.84% |
| 12 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,088,706 | $13.7M | 3.78% |
| 13 | ZYMEWORKS INC | ZYME | 820,000 | $12.0M | 3.32% |
| 14 | KURA ONCOLOGY INC | KURA | 1,325,000 | $11.5M | 3.19% |
| 15 | AMICUS THERAPEUTICS INC | FOLD | 920,000 | $8.7M | 2.40% |
| 16 | ZIMMER BIOMET HOLDINGS INC | ZBH | 80,000 | $8.5M | 2.34% |
| 17 | SYNDAX PHARMACEUTICALS INC | SNDX | 620,000 | $8.2M | 2.27% |
| 18 | SHATTUCK LABS INC | STTK | 6,638,935 | $8.0M | 2.22% |
| 19 | IMMUNOVANT INC | IMVT | 305,523 | $7.6M | 2.09% |
| 20 | BLUEPRINT MEDICINES CORP | 09627Y109 | 67,000 | $5.8M | 1.62% |
| 21 | PROTHENA CORP PLC | PRTA | 418,122 | $5.8M | 1.60% |
| 22 | GALAPAGOS NV | GLPGF | 176,900 | $4.9M | 1.34% |
| 23 | CYTOMX THERAPEUTICS INC | CTMX | 3,905,000 | $4.0M | 1.11% |
| 24 | HAEMONETICS CORP MASS | HAE | 46,700 | $3.6M | 1.01% |
| 25 | CENTENE CORP DEL | CNC | 55,000 | $3.3M | 0.92% |
| 26 | SIGHT SCIENCES INC | SGHT | 908,847 | $3.3M | 0.91% |
| 27 | LIVANOVA PLC | LIVN | 70,000 | $3.2M | 0.90% |
| 28 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 270,000 | $3.2M | 0.88% |
| 29 | ERASCA INC | ERAS | 947,110 | $2.4M | 0.66% |
| 30 | SPYRE THERAPEUTICS INC | SYRE | 80,000 | $1.9M | 0.51% |
| 31 | CAREDX INC | CDNA | 80,000 | $1.7M | 0.47% |
| 32 | MURAL ONCOLOGY PUB LTD CO | G63365103 | 466,822 | $1.5M | 0.42% |
| 33 | FORTREA HLDGS INC | FTRE | 55,100 | $1.0M | 0.28% |
| 34 | AILERON THERAPEUTICS INC | RNTX | 404,979 | $931,452 | 0.26% |
| 35 | IMMUNOME INC | IMNM | 54,342 | $577,112 | 0.16% |
| 36 | ONKURE THERAPEUTICS INC | OKUR | 63,754 | $548,284 | 0.15% |